@jimcramer @ScottGottliebMD Why doesn’t $BNTX / $MRNA use 1-2 bln of their cash to acquire #ProvidenceTherapeutics to get access to Chinese market through HK based #EverestMedicines partnership. They are currently in Ph2 for Covid mRNA program and they could get 2-4x back their money on investment.